News

Why do biologics lose efficacy over time? This physician discusses factors dermatologists should consider when they see this issue in their patients.

Derms don’t let other derms leave their office without SPF. Even more importantly, they shouldn’t ever let their post skin treatment patients leave without proper sun protection either.

Consider these 10 stats from the Allergan 360 Aesthetics Report for aesthetic practice marketing and more.

Mothers of children with atopic dermatitis may be more likely to experience difficulty falling asleep, insufficient sleep and daytime exhaustion, according to a recent study. 

Hosted by Dermatology Times and supported by Ortho Dermatologics, the hall of fame honored its inaugural class of inductees at the Long View Gallery in Washington, D.C., just before the 2019 American Academy of Dermatology Annual Meeting.

PricewaterhouseCoopers believes 2019 is the year a New Health Economy comes of age, according to its 13th annual report, "Top health industry issues of 2019." View the top six takeaways from the report in this slideshow.

The Dermatology Innovation Forum, a one-day pre-AAD meeting, gives physicians a frontline seat to founder stories, new innovations and major advances happening currently in dermatology. Here are some of the highlights from the 2019 DIF conference.

New research reports data on the effects the PFD patch has on thermal injury of the epidermis as well as airborne particle emissions.

According to this expert, honesty is the best policy – especially when appealing to insurance carriers on behalf of your patients.

In this month's Legal Eagle column, David J. Goldberg, M.D., J.D. discusses a scenario in which a physician tries to provide a better treatment option at a lower cost for his underinsured patients by importing medication from another country, but is reprimanded by the FDA. Find out why.

A recent study aimed to explore whether patients suffering from psoriasis carry serious medical morbidity, including cancer, that is not detected through history, physical exam and laboratory studies. 

The science looking at potential harmful effects of e-cigarettes is lagging, as e-cigarette popularity soars and consumer marketing takes hold convincing consumers that e-cigarettes are the safer of the two.

Researchers have developed a device that may eliminate the need for maps, guidelines or manual skin tension estimation techniques.

In many ways, 2018 was a banner year for new novel drug approvals with 59 drugs approved by the FDA’s Center for Drug Evaluation and Research (CDER). Learn about the innovative drugs that were approved for dermatological indications in this article. 

Key developments among new and emerging treatments for acne and rosacea include a novel oral agent and a novel topical agent, as well as new formulations of existing products, says Diane S. Berson, M.D. in her presentation at AAD.

Scars caused by acne can be both physical and emotional. Helping patients get the care they need starts with recognizing and addressing psychosocial issues that can be caused by acne, says Jonette E. Keri, M.D., Ph.D.

Oral contraceptive pills and antiandrogen therapies may rival antibiotics for women with acne, according to research presented by Rachel V. Reynolds, M.D. at AAD earlier this month.

Staphylococcus aureus infections are becoming more challenging to treat due to methicillin-resistant Staphylococcus aureus (MRSA). A better understanding of cutaneous immune mechanisms will identify specific immune mechanisms to target for future vaccines and immunotherapies to ultimately address this serious public health threat.

Consumer demand for body-shaping procedures stands out in newly released ASPS member stats.

Are cosmetic surgeons fostering the opioid epidemic?

Expert calls for FDA approval of devices for women’s genitourinary health: “Women need these treatments.”

Chief executive officer of Can-Fite Biopharmaceuticals, Pnina Fishman, Ph.D. discovered why cancer and inflammation can go everywhere in the body, except muscle tissue. Using this knowledge, Can-Fite has developed a promising psoriasis drug, piclidenoson, which is currently in phase 3 clinical trials.

Leadership and representation are becoming more important as the profession and demand for PAs grow. However, a recent study found that career satisfaction does not appear to be related to professional development benefits offered by employers. What fulfills physician assistants? Participate in this forum.

In this month's Legal Eagle column, David J. Goldberg, M.D., J.D., offers his insight on when to settle a malpractice lawsuit outside of court and when to take take it to trial.

Learn how the Food and Drug Administration (FDA) plays a critical role in the oversight of many medical devices used commonly in dermatology. 

From lasers to light therapy to non-laser-based thermal tightening, learn each devices' indications, adverse effects and important treatment takeaways.

Spring cleaning isn’t just for housework. It’s also a good time to clear away financial records, review what’s working, and change what isn’t.

Decluttering might just seem like the latest social media craze, but it’s benefits and challenges have deep psychological roots.

Drug-device combination, VP-102, met all primary and secondary endpoints in the parallel Cantharidin Application in Molluscum Patients (CAMP)-1 and CAMP-2 trials.

Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping. Andrew Blauvelt, M.D. discussed new drugs in the pipeline during American Academy of Dermatology Annual Meeting in Washington, D.C.